RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola
Investigational drugs opaganib and RHB-107 (upamostat) demonstrate distinct synergistic effect when combined individually with remdesivir, significantly improving potency while maintaining cell viability, in a new U.S. Army-funded and conducted in vitro Ebola virus study Opaganib and RHB-107 are both novel,…
New Drug Application of Mabwell’s 8MW0511 for Injection Accepted by NMPA
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug application of its recombinant (yeast-secreted) human serum albumin-human granulocyte colony-stimulating factor (I) fusion protein for injection (R&D code: 8MW0511) has been accepted by the National…
Sunrise Oncology Centre expands its horizon with a comprehensive cancer care unit in Mumbai
After setting up consecutive successful cancer care centers across Mumbai & Goa, Sunrise Oncology Centre inaugurates its latest comprehensive cancer care centre on 17th August 2023 in Andheri West, Mumbai. Founded in 2017 by the visionary trio Dr. Ashay Karpe,…
